LIQ861

Liquidia Submits New Drug Application for LIQ861 (treprostinil) Inhalation Powder to FDA for the Treatment of Pulmonary Arterial Hypertension (PAH) RESEARCH TRIANGLE PARK, N.C., Jan. […]

Read more
1 2 3 33